Navigation Links
SCAI Releases Position Statement on Public Reporting and Risk Adjustment In Cardiovascular Quality Improvement Programs
Date:5/5/2011

BALTIMORE, May 5, 2011 /PRNewswire/ -- A new position statement released today by the Society for Cardiovascular Angiography and Interventions (SCAI) calls for changes in the way quality of percutaneous coronary intervention (PCI, also known as angioplasty) care is measured and publically reported. The position statement, released during the SCAI 2011 Scientific Sessions and published online in Catheterization and Cardiovascular Interventions (CCI), reviews current standards for public reporting, risk adjustment and the role of volume as an indicator for quality of care.

Increasingly, policymakers and regulators are evaluating publically reported quality health care measures in an effort to curb costs and help improve patient care.  However, many of today's standards are inadequate for judging the true quality of care delivered in a hospital or by an individual physician. For public reporting to facilitate quality improvement that yields better patient outcomes, clinical data must be accurately and consistently collected and outcomes must be risk-adjusted to account for the health of the patient.

"The interventional cardiology community supports the idea that improved patient outcomes is the primary goal in transforming health care, because it will improve our patients' health and reduce medical costs," said Lloyd W. Klein, M.D., FSCAI, professor of Medicine at Rush Medical College and lead author of the statement. "But to do so, we need to ensure we are collecting and sharing the best possible information. That means quality measures that are risk-adjusted and based on clinical data from the patient's medical chart."

The statement recommends quality measures based on:

  • Validated risk-adjustment models for mortality and major complications
  • 30-day mortality, to follow patients after they leave the hospital
  • Clinical data taken from patients' medical charts, not claims information intended for billing purposes currently used by many quality programs
  • Data collected in a nationally or regionally benchmarked database

In addition, the statement calls for a means of assessing clinical appropriateness of PCI procedures.  Based on the recommendations outlined in this position statement, SCAI is advocating for:

  • A mechanism for accurately defining and measuring 30-day mortality outcomes post PCI procedure, using a risk-adjusted model that considers all major complications directly associated with PCI, not just all-cause mortality – a metric that does not always correlate to a patient's PCI procedure and therefore is not always an accurate measure of outcomes.
  • A means to benchmark programmatic results against national standards, as reported in to databases such as the NCDR CathPCI Registry, to identify best practices and standards of care to improve patient outcomes, as well as identify areas in need of correction and refinement and make those adjustments in clinical practice.

"We need to understand the patient's outcome following a procedure, and we also need to understand how sick the patient was prior to the procedure and whether it was appropriate given the patient's condition," said Dr. Klein. "As quality is increasingly reported, we must ensure we do so in a way that is appropriately measuring true outcomes – highlighting where care was effective and also where it was ineffective – and using that information to improve care for all our patients."

The statement is the second of a two-part report developed by SCAI to address quality assessment and improvement in interventional cardiology. It can be accessed at http://onlinelibrary.wiley.com/doi/10.1002/ccd.23153/pdf or www.SCAI.org.  The first statement released in March 2011, addressed core standards and measures of assessing quality of interventional programs.

About SCAI

Headquartered in Washington, D.C., the Society for Cardiovascular Angiography and Interventions is a 4,000-member professional organization representing invasive and interventional cardiologists in approximately 70 nations. SCAI's mission is to promote excellence in invasive and interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. SCAI's annual meeting has become the leading venue for education, discussion, and debate about the latest developments in this dynamic medical specialty. SCAI's patient and physician education program, Seconds Count, offers comprehensive information about cardiovascular disease. For more information about SCAI and Seconds Count, visit www.scai.org or www.SecondsCount.org.


'/>"/>
SOURCE Society for Cardiovascular Angiography and Interventions (SCAI)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. CEL-SCI Corporation Releases Letter to Shareholders
3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Immunosyn Corporation Releases SF-1019 Study Results
6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
Breaking Medicine News(10 mins):